...
首页> 外文期刊>The Journal of Nuclear Medicine >Positive Clinical Impact of an Additional PET/CT Scan Before Adjuvant Radiotherapy or Concurrent Chemoradiotherapy in Patients with Advanced Oral Cavity Squamous Cell Carcinoma
【24h】

Positive Clinical Impact of an Additional PET/CT Scan Before Adjuvant Radiotherapy or Concurrent Chemoradiotherapy in Patients with Advanced Oral Cavity Squamous Cell Carcinoma

机译:晚期口腔腔鳞状细胞癌患者在辅助放疗或同时放化疗之前进行额外的PET / CT扫描对临床的积极影响

获取原文
获取原文并翻译 | 示例

摘要

The aim of this single-center study was to investigate whether obtaining an additional PET/CT scan before adjuvant radiotherapy or concurrent chemoradiotherapy (CCRT) could meaningfully improve 2-y disease-free survival (DFS) and disease-specific survival (DSS) rates. Methods: Six hundred seventy-four patients with oral cavity squamous cell carcinoma who received adjuvant therapy after radical surgery were included. Of these, 152 patients were initially scheduled to receive an additional preradiotherapy/CCRT PET/CT scan within 1 wk of starting adjuvant therapy. However, 16 patients were excluded because of either medical problems or refusal. Therefore, 136 patients underwent a preradiotherapy/CCRT PET/ CT scan (PET group), and 522 did not (NO-PET group). All of the participants were followed up for at least 2 y or censored at the last follow-up. The impact of preradiotherapy/CCRT PET/CT imaging was examined using Kaplan-Meier curves and Cox proportional hazards models. Results: Two-year DFS (80% vs. 70%, P = 0.033) and DSS (84% vs. 75%, P = 0.010) rates were significantly higher in the PET than in the NO-PET group. In the PET group, both DFS and DSS were higher in patients with negative findings than in those without (88% vs. 22% and 91% vs. 36%, respectively; both P < 0.001). A prognostic scoring system based on the presence of the 2 independent risk factors in the PET group (extracapsular spread and lymphatic invasion) predicted both DFS (P = 0.001 and P, 0.001, respectively) and DSS (P = 0.001 and P < 0.001, respectively). Nineteen patients (14%) had their treatment modified by preradiotherapy/CCRT PET/CT findings. Of these, 15 were treated with curative intent due to the presence of locoregional disease, and 4 received palliative care due to distant metastases. Seven of the 15 patients are currently alive without disease. Conclusion: An additional preradiotherapy/CCRT PET/CT scan improves both DFS and DSS in patients with advanced oral cavity squamous cell carcinoma.
机译:这项单中心研究的目的是调查在辅助放疗或同步放化疗之前进行额外的PET / CT扫描是否可以有意义地提高2-y无病生存率(DFS)和疾病特异性生存率(DSS) 。方法:纳入674例经根治性手术后接受辅助治疗的口腔鳞状细胞癌患者。在这些患者中,最初有152名患者计划在开始辅助治疗后1周内接受额外的放射治疗/ CCRT PET / CT扫描。但是,有16位患者由于医疗问题或拒绝而被排除在外。因此,有136例患者接受了放射治疗/ CCRT PET / CT扫描(PET组),而有522例没有进行(NO-PET组)。对所有参与者进行至少2年的随访或在最后一次随访中进行检查。使用Kaplan-Meier曲线和Cox比例风险模型检查了放疗/ CCRT PET / CT成像的影响。结果:PET的两年DFS(80%对70%,P = 0.033)和DSS(84%对75%,P = 0.010)的发生率显着高于NO-PET组。在PET组中,发现阴性的患者的DFS和DSS均高于未发现阴性的患者(分别为88%比22%和91%比36%;两者均P <0.001)。根据PET组中2个独立的危险因素(囊外扩散和淋巴管浸润)的存在,进行预后评分系统可预测DFS(分别为P = 0.001和P,0.001)和DSS(P = 0.001和P <0.001,分别)。 19名患者(14%)因放疗/ CCRT PET / CT检查结果而改变了治疗方法。在这些患者中,有15例由于局部区域疾病的存在而得到了治愈,而4例由于远处转移而得到了姑息治疗。 15名患者中有7名目前尚无疾病。结论:额外的放射治疗/ CCRT PET / CT扫描可改善晚期口腔鳞状细胞癌患者的DFS和DSS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号